Insights
From a population health perspective, the need to more effectively treat neurological dysfunction is pressing, as millions of people around the world will develop a treatment-resistant or incurable neurological disease every year. The pharmaceutical industry and Big Tech are leveraging scientific and technological advancements to spur innovation, like the scaling-up of genomic approaches, novel delivery systems that can cross the bloodbrain barrier, and new biomarkers to diagnose and treat disease sooner. Across the United States, Europe and Asia, various largescale investments and well-funded initiatives are fueling growth, which was coined this year in Nature as the “neuroscience brainstorm.”
Download Whitepaper: Neuroscience Brainstorm: Trends in Innovation and Investment
By providing my email address, I agree to ClearView's online policies